Get the Stockscreener App
2.68
10.29%
0.25
After Hours:
2.61
-0.07
-2.61%
Armata Pharmaceuticals Inc Stock (ARMP) Forecast
The Armata Pharmaceuticals Inc (ARMP) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $2.2654, representing a -15.47% decrease from the current price of $2.68. The highest analyst price target is $2.5916, and the lowest is $1.9391.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ARMP Price Target
Average 5.0213
(+87.36% Upside)
Is Armata Pharmaceuticals Inc (ARMP) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 62.55 | Neutral |
| STOCH(9,6) | 58.61 | Neutral |
| STOCHRSI(14) | 59.32 | Neutral |
| MACD(12,26) | 0.0885 | Buy |
| ADX(14) | 41.35 | Buy |
| William %R | -10.14 | Sell |
| CCI(14) | 69.59 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.5003
Buy
|
2.5453
Buy
|
| MA20 |
2.4972
Buy
|
2.4838
Buy
|
| MA50 |
2.2587
Buy
|
2.294
Buy
|
| MA100 |
1.8937
Buy
|
2.1265
Buy
|
| MA200 |
1.9907
Buy
|
2.1258
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, ARMP could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 1 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on ARMP, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 62.55 indicates that ARMP is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 58.61 indicates that ARMP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 59.32 indicates that ARMP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 41.35 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 69.59 indicates that ARMP is still overbought but not to an extreme extent.
Long-term ARMP price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Armata Pharmaceuticals Inc financial reports and earnings history, Armata Pharmaceuticals Inc (ARMP) stock could reach $1.425 by 2030, $1.8037 by 2040 and $1.3679 by 2050. See the projected annual prices until 2050 of the Armata Pharmaceuticals Inc stock below:
- Armata Pharmaceuticals Inc (ARMP) is expected to reach an average price of $0.1267 in 2035, with a high prediction of $0.7583 and a low estimate of $0.0216. This indicates an $-95.27% rise from the last recorded price of $2.68.
- Armata Pharmaceuticals Inc (ARMP) stock is projected to chart a bullish course in 2040, with an average price target of $1.8687, representing an $-30.27% surge from its current level. The forecast ranges from a conservative $1.9762 to a sky-high $1.8037.
- Our analysts predict Armata Pharmaceuticals Inc (ARMP) to jump -67.54% by 2045, soaring from $0.98 to an average price of $0.87, potentially reaching $0.7999. While $0.98 is the low estimate, the potential upside is significant.
- Armata Pharmaceuticals Inc (ARMP) stock is expected to climb by 2050, reaching an average of $1.3254, a $-50.54% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1.3679 and $1.6127, respectively, highlighting the market's uncertainty.
Armata Pharmaceuticals Inc Stock (ARMP) Year by Year Forecast
Armata Pharmaceuticals Inc Stock (ARMP) Price Forecast for 2025
Armata Pharmaceuticals Inc Stock (ARMP) is expected to reach an average price of $3.1138 in 2025, with a high prediction of $5.2845 and a low estimate of $0.9432. This indicates an +16.19% rise from the last recorded price of $2.68.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| September, 2025 | $1.9891 | $1.9391 | $2.5916 | -25.78% |
| October, 2025 | $1.4115 | $1.2915 | $2.0916 | -47.33% |
| November, 2025 | $1.6515 | $1.342 | $2.2465 | -38.38% |
| December, 2025 | $1.5939 | $1.424 | $2.3689 | -40.53% |
Armata Pharmaceuticals Inc Stock (ARMP) Price Forecast for 2026
The predicted value for Armata Pharmaceuticals Inc (ARMP) in 2026 is set at an average of $5.0213. Estimates vary from a peak of $8.9887 to a trough of $1.0538, indicating an +87.36% surge from the present price of $2.68.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.6539 | $1.5164 | $2.467 | -38.29% |
| February, 2026 | $1.2538 | $1.0538 | $1.9388 | -53.22% |
| March, 2026 | $1.8638 | $1.2563 | $2.3038 | -30.46% |
| April, 2026 | $4.2562 | $1.7063 | $8.9887 | +58.81% |
| May, 2026 | $3.8562 | $2.6912 | $4.8262 | +43.89% |
| June, 2026 | $3.1261 | $3.0141 | $4.7486 | +16.65% |
| July, 2026 | $2.5385 | $2.3823 | $3.2007 | -5.28% |
| August, 2026 | $3.1485 | $2.421 | $3.2585 | +17.48% |
| September, 2026 | $2.5809 | $2.486 | $3.3496 | -3.70% |
| October, 2026 | $2.4009 | $2.3234 | $2.7284 | -10.41% |
| November, 2026 | $2.2008 | $2.1883 | $2.5783 | -17.88% |
| December, 2026 | $2.2233 | $2.1141 | $2.5883 | -17.04% |
Armata Pharmaceuticals Inc Stock (ARMP) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Armata Pharmaceuticals Inc (ARMP) is $3.2757, with a high forecast of $5.1157 and a low forecast of $1.4357. This indicates an +22.23% increase from the last price of $2.68.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.6332 | $1.6332 | $2.3958 | -39.06% |
| February, 2027 | $2.5432 | $1.4357 | $3.6232 | -5.11% |
| March, 2027 | $3.6756 | $2.2557 | $5.1157 | +37.15% |
| April, 2027 | $4.4056 | $3.5081 | $5.1034 | +64.39% |
| May, 2027 | $3.7755 | $3.208 | $4.458 | +40.88% |
| June, 2027 | $3.6779 | $3.2964 | $4.3579 | +37.24% |
| July, 2027 | $3.5679 | $2.4229 | $4.2804 | +33.13% |
| August, 2027 | $2.9778 | $2.9778 | $4.4729 | +11.11% |
| September, 2027 | $2.8703 | $2.3563 | $3.5591 | +7.10% |
| October, 2027 | $2.3302 | $2.2602 | $3.4577 | -13.05% |
| November, 2027 | $2.2202 | $1.6827 | $2.7652 | -17.16% |
| December, 2027 | $2.9526 | $2.0327 | $3.2326 | +10.17% |
Armata Pharmaceuticals Inc Stock (ARMP) Price Forecast for 2028
In 2028, Armata Pharmaceuticals Inc (ARMP) is projected to reach an average price of $1.8403, with a high projection of $3.6725 and a low estimate of $0.00804. This indicates an -31.33% fall from the last price of $2.68.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.7726 | $2.6226 | $3.2351 | +3.45% |
| February, 2028 | $2.9725 | $1.8675 | $3.6725 | +10.91% |
| March, 2028 | $1.6849 | $1.6825 | $3.015 | -37.13% |
| April, 2028 | $0.7849 | $0.6249 | $2.1699 | -70.71% |
| May, 2028 | $0.0773 | $0.0673 | $1.1799 | -97.11% |
| June, 2028 | $1.4573 | $0.1077 | $1.7073 | -45.62% |
| July, 2028 | $1.5422 | $1.1408 | $2.5598 | -42.45% |
| August, 2028 | $0.7897 | $0.7197 | $2.4197 | -70.53% |
| September, 2028 | $0.4096 | $0.2346 | $0.8122 | -84.72% |
| October, 2028 | $0.3196 | $0.2196 | $0.5371 | -88.08% |
| November, 2028 | $0.462 | $0.0571 | $0.552 | -82.76% |
| December, 2028 | $0.00196 | $0.00804 | $0.5545 | -99.93% |
Armata Pharmaceuticals Inc Stock (ARMP) Price Forecast for 2029
The 2029 price forecast for Armata Pharmaceuticals Inc Stock (ARMP) is $2.0776 on average, with a high prediction of $4.1384 and a low estimate of $0.0169. This represents an -22.48% decrease from the previous price of $2.68.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.3644 | $0.0169 | $2.0419 | -49.09% |
| February, 2029 | $1.8143 | $1.1969 | $4.1384 | -32.30% |
| March, 2029 | $1.5943 | $1.5543 | $2.5768 | -40.51% |
| April, 2029 | $0.9642 | $0.9142 | $2.0683 | -64.02% |
| May, 2029 | $1.4967 | $0.8092 | $1.5867 | -44.15% |
| June, 2029 | $1.2966 | $0.8517 | $1.8392 | -51.62% |
| July, 2029 | $2.1766 | $1.003 | $2.4159 | -18.78% |
| August, 2029 | $2.739 | $1.7092 | $3.049 | +2.20% |
| September, 2029 | $1.959 | $1.7137 | $3.074 | -26.90% |
| October, 2029 | $2.7114 | $1.7815 | $3.4464 | +1.17% |
| November, 2029 | $1.6464 | $1.4814 | $3.2263 | -38.57% |
| December, 2029 | $0.66 | $0.22 | $2.82 | -75.37% |
Armata Pharmaceuticals Inc Stock (ARMP) Price Forecast for 2030
Armata Pharmaceuticals Inc Stock (ARMP) is expected to reach an average price of $1.8376 in 2030, with a high forecast of $3.6489 and a low forecast of $0.0263. This signifies an -31.43% decrease from the last price of $2.68.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.3551 | $0.3051 | $1.425 | -86.75% |
| February, 2030 | $0.0252 | $0.1352 | $0.6698 | -99.06% |
| March, 2030 | $0.2847 | $0.0703 | $0.3147 | -89.38% |
| April, 2030 | $1.0946 | $0.0946 | $1.4496 | -59.16% |
| May, 2030 | $0.3294 | $0.2879 | $1.4645 | -87.71% |
| June, 2030 | $0.7694 | $0.0344 | $1.0393 | -71.29% |
| July, 2030 | $0.8842 | $0.6442 | $1.3192 | -67.01% |
| August, 2030 | $0.7767 | $0.6641 | $1.2492 | -71.02% |
| September, 2030 | $0.216 | $0.1909 | $0.5491 | -91.94% |
| October, 2030 | $0.8689 | $0.2339 | $3.6489 | -67.58% |
| November, 2030 | $0.2812 | $0.2912 | $1.2739 | -89.51% |
| December, 2030 | $0.0413 | $0.0263 | $0.3407 | -98.46% |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):